Maximising Efficiency of Spatial Transcriptomics in Scleroderma: Challenges and Opportunities
Scleroderma (SSc) is a chronic, multi-system, auto-immune me diated disease that impacts up to 240 million people worldwide [1].
Journal of Clinical and Medical Images (ISSN 2640-9615)
(ISSN 2640-9615)
Scleroderma (SSc) is a chronic, multi-system, auto-immune me diated disease that impacts up to 240 million people worldwide [1].